βig-h3 represses T-cell activation in type 1 diabetes

Diabetes

Volumn 64, Issue 12, 2015, Pages 4212-4219

  Patry, Maeva ^a,b,c   Teinturier, Romain ^a,b,c   Goehrig, Delphine ^a,b,c   Zetu, Cornelia ^d   Ripoche, Doriane ^a,b,c   Kim, In San ^e,f   Bertolino, Philippe ^a,b,c   Hennino, Ana ^a,b,c  

^a CNRS   (France)

^b UNIVERSITÉ LYON 1   (France)

^c CENTRE LÉON BÉRARD   (France)

^d Nutrition and Metabolic Diseases 'N Paulescu'   (Romania)

^e Korea Institute of Science and Technology   (South Korea)

^f Korea University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANZYME B; PROTEIN KINASE LCK; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; ANTIDIABETIC AGENT; BETAIG-H3 PROTEIN; BIOLOGICAL MARKER; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN KINASE INHIBITOR; RECOMBINANT PROTEIN; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; ANTAGONISTS AND INHIBITORS; AUTOIMMUNITY; C57BL MOUSE; CADAVER; CELL CULTURE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; GENETICS; GERMFREE ANIMAL; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPH NODE; LYMPHOCYTE ACTIVATION; METABOLISM; NONOBESE DIABETIC MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; AUTOIMMUNITY; BIOMARKERS; CADAVER; CELLS, CULTURED; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; LYMPH NODES; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); MICE, INBRED C57BL; MICE, INBRED NOD; MICE, KNOCKOUT; PROTEIN KINASE INHIBITORS; RECEPTORS, ANTIGEN, T-CELL; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SPECIFIC PATHOGEN-FREE ORGANISMS; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA;

EID: 84962163347     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db15-0638     Document Type: Article

References (24)

1. DiLorenzo TP, Lieberman SM, Takaki T, et al. During the early prediabetic period in NOD mice, the pathogenic CD8(+) T-cell population comprises multiple antigenic specificities. Clin Immunol 2002;105:332-341
2. Tsai S, Shameli A, Santamaria P. CD8+ T cells in type 1 diabetes. Adv Immunol 2008;100:79-124
3. Zhao N, Hao J, Ni Y, et al. Vg4 gd T cell-derived IL-17A negatively regulates NKT cell function in Con A-induced fulminant hepatitis. J Immunol 2011;187: 5007-5014
4. Skonier J, Bennett K, Rothwell V, et al. Beta ig-h3: a transforming growth factor-beta-responsive gene encoding a secreted protein that inhibits cell attachment in vitro and suppresses the growth of CHO cells in nude mice. DNA Cell Biol 1994;13:571-584
5. Hashimoto K, Noshiro M, Ohno S, et al. Characterization of a cartilage-derived 66-kDa protein (RGD-CAP/beta ig-h3) that binds to collagen. Biochim Biophys Acta 1997;1355:303-314
6. Choi Q, Hong KH, Kim JE, Kim HK. Changes in plasma levels of natural anticoagulants in disseminated intravascular coagulation: high prognostic value of antithrombin and protein C in patients with underlying sepsis or severe infection. Ann Lab Med 2014;34:85-91
7. Han B, Qi S, Hu B, Luo H, Wu J. TGF-beta i promotes islet beta-cell function and regeneration. J Immunol 2011;186:5833-5844
8. Han KJ, Lee SY, Kim NH, et al. Increased risk of diabetes development in subjects with the hypertriglyceridemic waist phenotype: a 4-year longitudinal study. Endocrinol Metab (Seoul) 2014;29:514-521
9. Like AA, Rossini AA. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 1976;193:415-417
10. Wu Y, Han B, Luo H, et al. DcR3/TR6 effectively prevents islet primary nonfunction after transplantation. Diabetes 2003;52:2279-2286
11. Manders EMM, Verbeek FJ, Aten JA. Measurement of co-localization of objects in dual-colour confocal images. J Microsc 1993;169:375-382
12. Savage PA, Boniface JJ, Davis MM. A kinetic basis for T cell receptor repertoire selection during an immune response. Immunity 1999;10:485-492
13. Tumbarello DA, Temple J, Brenton JD. b3 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cells. Mol Cancer 2012;11:36
14. Goda S, Quale AC, Woods ML, Felthauser A, Shimizu Y. Control of TCR-mediated activation of beta 1 integrins by the ZAP-70 tyrosine kinase interdomain B region and the linker for activation of T cells adapter protein. J Immunol 2004;172:5379-5387
15. Cimo AM, Ahmed Z, McIntyre BW, Lewis DE, Ladbury JE. CD25 and CD69 induction by a4b1 outside-in signalling requires TCR early signalling complex proteins. Biochem J 2013;454:109-121
16. Davis SJ, van der Merwe PA. Lck and the nature of the T cell receptor trigger. Trends Immunol 2011;32:1-5
17. Rhee I, Veillette A. Protein tyrosine phosphatases in lymphocyte activation and autoimmunity. Nat Immunol 2012;13:439-447
18. Yamaguchi H, Hendrickson WA. Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation. Nature 1996;384:484-489
19. Boggon TJ, Eck MJ. Structure and regulation of Src family kinases. Oncogene 2004;23:7918-7927
20. Nika K, Soldani C, Salek M, et al. Constitutively active Lck kinase in T cells drives antigen receptor signal transduction. Immunity 2010;32:766-777
21. Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 1980;29: 1-13
22. Bachmann MF, McKall-Faienza K, Schmits R, et al. Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation. Immunity 1997;7:549-557
23. Nervi S, Atlan-Gepner C, Kahn-Perles B, et al. Specific deficiency of p56lck expression in T lymphocytes from type 1 diabetic patients. J Immunol 2000;165: 5874-5883
24. Milstein O, Hagin D, Lask A, et al. CTLs respond with activation and granule secretion when serving as targets for T-cell recognition. Blood 2011; 117:1042-1052